Hedge End town house on the market for £375,000
A well-presented town house in Hedge End is on the market for £375,000.
The three/four bedroom property, in White's Way, benefits from a southerly-facing rear garden, a garage to the rear, and an allocated parking space to the front.
The accommodation on the ground floor comprises of an open plan kitchen/diner/family room, measuring over 26ft, with French doors leading to the rear garden.
The modern fitted kitchen has a built-in double oven and gas hob, along with integrated appliances including a fridge/freezer, dishwasher, and washing machine.
Modern fitted kitchen includes a double oven, gas hob, and integrated fridge/freezer, dishwasher, and washing machine (Image: Zoopla/White & Guard) The ground floor also features a modern WC.
The first floor houses a spacious sitting room, currently used as an additional bedroom, overlooking the rear garden.
There is another bedroom with a built-in wardrobe and a family bathroom comprising a panel enclosed bath, wash hand basin and WC.
The top floor contains two double bedrooms, with the master bedroom having fitted storage, an en-suite shower room, and a window to the rear.
Southerly-facing rear garden with lawn, planted borders, decked seating area, and gated access to a single garage (Image: Zoopla/White & Guard) The other bedroom has a window to the front and a fitted wardrobe.
The estate agent White & Guard Estate Agents said the property is "well-presented throughout".
They added: "The property is conveniently situated within walking distance of Hedge End's train station and Dowd's Farm Park, as well as close to local shops, schools and amenities, including the M27 motorway links."
The estate agent also highlighted the southerly-facing rear garden, which has a decked seating area, with the rest of the garden mainly laid to lawn with planted borders and gated, rear pedestrian access leading to the single garage.
According to the Openreach website, full fibre broadband is available at the property, with download speeds of up to 1600 Mbps and upload speeds of up to 115 Mbps.
The property has an EPC grade of B and falls under the Eastleigh council band C.
Gas, water, electricity, and mains drainage are connected to the property.
However, White & Guard Estate Agents noted that none of the services or appliances have been tested by them.
The property is listed as freehold, and the estate agents can be contacted directly for more information or to arrange a viewing.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world's oldest and most prestigious tennis tournament serves as a perfect backdrop to showcase Smith+Nephew's purpose of 'Life Unlimited' - making a difference in patients' lives through the excellence of a diverse Sports Medicine product portfolio and the application of new is a high-impact sport that places great stress on various areas of the body – especially joints – often resulting in injury. Some of the latest technologies and solutions from Smith+Nephew for joint repair include: REGENETEN◊ Bioinductive Implant: With more than 150,000 procedures1 completed globally since its introduction in 2014, the REGENETEN Bioinductive Implant has had a transformative impact amongst those having surgery for rotator cuff tears; demonstrating lower re-tear rates than reported compared to conventional techniques.2-6 Backed by level one clinical evidence,2 the collagen-based implant supports the body's natural healing response to facilitate the formation of new tendon-like tissue to biologically augment the existing tendon and change the course of rotator cuff tear progression.7-12 CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant: Derived from a naturally occurring calcium carbonate known as aragonite, the CARTIHEAL Implant is a biphasic scaffold for cartilage repair and subchondral bone restoration.13-15 Shown to deliver clinically meaningful post-operative improvements in pain, function and quality of life,* the CARTIHEAL Implant is the only device approved for the treatment of knee cartilage and osteochondral defects in patients with or without mild to moderate osteoarthritis (KL 0-3).13,16 Q-FIX◊ KNOTLESS All-Suture Anchor: Building on the long-standing success and performance of the Q-FIX Family for best-in-class anchor fixation strength,**,17-21 the new Q-FIX KNOTLESS All-Suture Anchor raises the bar for all-suture anchor technology. With proprietary features and capabilities, the Q-FIX KNOTLESS All-Suture Anchor aims to set a new benchmark for soft tissue security†,22 and offer surgeons a new option for soft tissue-to-bone fixation indications across multiple joint spaces. 'Our inaugural turn sponsoring select players during The Championships, Wimbledon in 2024 was a tremendous success supporting athletes from across the globe - including Jasmine Paolini all the way to the Ladies Final,' said Christie van Geffen, SVP Global Sports Medicine Marketing for Smith+Nephew. 'We were able to uniquely feature the Smith+Nephew brand along with our leading Sports Medicine technology portfolio - designed to help weekend warriors and world-class athletes get back to competing and doing what they love.' If you would like to learn more about Smith+Nephew's leading Sports Medicine technology portfolio – including the CARTIHEAL AGILI-C Cartilage Repair Implant, the REGENETEN Bioinductive Implant and the Q-FIX KNOTLESS All-Suture Anchor - please visit here. - ends – Media Enquiries Dave Snyder +1 (978) 749-1440 Smith+Nephew *Over a 2 and 4 year follow up **As compared to competitive devices in fixation/pull-out benchtop testing †As compared to the competitive device in cyclic benchtop testing References Smith+Nephew. Internal Data. Ruiz Ibán MÁ, García Navlet M, Moros Marco S, et al. Augmentation of a Transosseous-Equivalent Repair in Posterosuperior Nonacute Rotator Cuff Tears With a Bioinductive Collagen Implant Decreases the Retear Rate at One Year: A Randomized Controlled Trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2023:1-14. Bushnell BD, Connor PM, Harris HW, et al. Retear rates and clinical outcomes at 1 year after repair of full-thickness rotator cuff tears augmented with a bioinductive collagen implant: a prospective multicenter study. JSES international. 2021;5(2):228. Hein J, Reilly JM, Chae J, Maerz T, Anderson K. Retear Rates After Arthroscopic Single-Row, Double Row, and Suture Bridge Rotator Cuff Repair at a Minimum of 1 Year of Imaging Follow-up: A Systematic Review. Arthroscopy. 2015;31(11):2274-2281. Camacho-Chacon JA, Cuenca-Espierrez J, Roda-Rojo V, et al. Bioinductive collagen implants facilitate tendon regeneration in rotator cuff tears. J Exp Orthop. 2022;9(1):53. Smith + Nephew overview of the outcomes associated with the standard of care for the surgical treatment of rotator cuff tears. Internal Report EO/SPM/REGENETEN/005/v1. Bokor DJ, Sonnabend D, Deady L, et al. Evidence of healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a collagen implant: a 2-year MRI follow-up. Muscles, Ligaments Tendons J. 2016;6(1):16-25. Schlegel TF, Abrams JS, Bushnell BD, Brock JL, Ho CP. Radiologic and clinical evaluation of a bioabsorbable collagen implant to treat partial-thickness tears: a prospective multicenter study. J Shoulder Elbow Surg. 2018 27(2):242-251. Van Kampen C, Arnoczky S, Parks P, et al. Tissue-engineered augmentation of a rotator cuff tendon using a reconstituted collagen scaffold: a histological evaluation in sheep. Muscles Ligaments Tendons J. 2013;3(3):229-235. Arnoczky SP, Bishai SK, Schofield B, et al. Histologic Evaluation of Biopsy Specimens Obtained After Rotator Cuff Repair Augmented With a Highly Porous Collagen Implant. Arthroscopy. 2017;33(2):278-283 Bokor DJ, Sonnabend DH, Deady L, et al. Healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a highly porous collagen implant: a 5-year clinical and MRI follow-up. Muscles, Ligaments Tendons J. 2019;9(3):338-347. McElvany MD, McGoldrick E, Gee AO, Neradilek MB, Matsen FA, 3rd. Rotator cuff repair: published evidence on factors associated with repair integrity and clinical outcome. Am J Sports Med. 2015;43(2):491-500. Altschuler N, Zaslav KR, Di Matteo B, et al. Aragonite-Based Scaffold Versus Microfracture and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions: Results of a Multicenter Randomized Controlled Trial. Am J Sports Med. 2023;51(4):957-967. doi:10.1177/03635465231151252 Kon E, Di Matteo B, Verdonk P, et al. Aragonite-Based Scaffold for the Treatment of Joint Surface Lesions in Mild to Moderate Osteoarthritic Knees: Results of a 2-Year Multicenter Prospective Study. Am J Sports Med. 2021;49(3):588-598. Kon E, Filardo G, Shani J, et al. Osteochondral regeneration with a novel aragonite-hyaluronate biphasic scaffold: up to 12-month follow-up study in a goat model. J Orthop Surg Res. 2015;10:81. Conte P, Anzillotti G, Crawford DC, et al. Differential analysis of the impact of lesions' location on clinical and radiological outcomes after the implantation of a novel aragonite-based scaffold to treat knee cartilage defects. Int Orthop. 2024;48(12):3117-3126 Douglass NP, et al. Arthroscopy. 2017;33(5):977-985 e975. Ergun S, et al. Arthroscopy. 2020; 2(3):e263-e275. Smith+Nephew 2023. Internal Report. 10090792- Revision B. ArthroCare Corporation 2017. Internal Report. P/N 49190-03 Rev. B. Smith+Nephew 2024. Internal Report. 10144423 Rev B. Smith and Nephew 10144423 Rev B About Smith+Nephew Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 17,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise. For more information about Smith+Nephew, please visit and follow us on X, LinkedIn, Instagram or Facebook. Forward-looking Statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC's website at www. for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations. ◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.
Yahoo
42 minutes ago
- Yahoo
UK households urged to check broadband deals now to get full fibre without paying more
Millions of UK households have been urged to check if they can get full fibre without paying a penny more. has said around 11 million homes across the UK could get access to the high internet speeds but are unaware of the broadband deals currently on offer. Many of which could be entitled to a free upgrade, as the government continues to push for access to full fibre nationwide by 2030. Read more: Martin Lewis' MSE delivers verdict on if Premium Bonds 'worth it' after cuts The Labour government has set a goal to bring 85% of the nation into the fastest internet speed by this year. Matt Sanders from said: "Note down the key details of your current broadband deal, such as the connection type, speeds you've been promised and what you're paying." To check your eligibility for full fibre broadband, comparison sites such as MoneySuperMarket detail the best deals currently on offer. All you need to do is punch in your postcode and it will show which internet providers have coverage in your area. If your current provider is listed, but you don't have full fibre, then you may be due an upgrade. and Which? offer broadband speed check tools to compare how fast your internet is and what is currently available on the market. It comes as Broadband Genie has named the internet providers that are best for online gaming, working from home, and streaming in its annual awards. The annual survey named Plusnet as the 'Best Broadband Provider' of the year based off a OnePoll survey of 3,997 broadband bill payers, as well as an analysis of 291,467 broadband speed tests that were run over a 12-month period. Broadband Genie expert Alex Tofts said: 'Customer service is an area which can make or break a positive experience with your internet provider. "Get it right, and customers feel valued and looked after. Get it wrong, and customers will be left frustrated, unheard and will want to look elsewhere. "We can only hope these big players will be pulling their socks up to improve their services. It's no surprise that in a year when customers are once again having to swallow hefty mid-contract price rises that they feel they're not getting value for money. "This is more evidence and only affirms our stance that Ofcom needs to ban mid-contract price rises.' Plusnet won 'Best Provider' as 79% of users rated them the best. The 'Fastest Widely Available Provider' was Virgin Media 188Mbps (average download), while Vodafone secured 'Best Value for Money'.
Yahoo
an hour ago
- Yahoo
NIO stock has halved. Could it double in future?
Over the past five years, carmaker NIO (NYSE: NIO) has seen sales surge. First-quarter revenues were down 39% compared to the fourth quarter of last year – but they were up 877% over five years. At around £1.2bn for the three months in question, they are substantial. Yet, despite surging sales revenues, NIO stock has fallen 50% in five years. Could that offer me an interesting investment opportunity? After all, even if the share price just gets back to where it stood five years ago, that would mean doubling money put in today. The idea of a share price 'just getting back' to where it used to be can be appealing but has no real basis in logic. I would like my looks to get back to where they were five years ago – but that does not mean it will happen. Instead, the question I need to ask as an investor is what I think a reasonable price for NIO stock would be and whether I see drivers that could help push it there. Here, things become problematic for the current NIO investment case as I see it. Sure, sales volumes and revenues have surged. So what accountants call the 'top line' (revenues) is doing well. The problem is all the costs that sit between that and the 'bottom line'. In NIO's case, the bottom line is not a profit, but a loss. At close to £700m in the most recent quarter alone, it is substantial. This is the key challenge I see with NIO. It has been consistently loss-making and burnt through lots of cash. It ended the quarter with around £2.6bn of cash and cash equivalents, restricted cash, short-term investments, and long-term time deposits. But if it keeps burning cash like it has been, I do not see that lasting much more than a couple of years at most. NIO could try to raise more cash, at the risk of diluting existing shareholders. My bigger concern as a potential investor is not about the cash burn so much as the business model. Rival Tesla bled cash for years before it became profitable. Making cars is an expensive business with high fixed costs. But, with even Tesla now seeing car sales volumes falling, it is clear that the electric vehicle market is highly competitive. That could be bad news for smaller players, including Nio. The company has pinned a lot on its battery-swapping technology, explaining some of its cash burn. But the potential for significantly longer battery ranges could leave that competitive advantage dead in the water. NIO would then need to rely more on its brand, design, and other features that help set it apart from rivals. Again, though, it is not the only carmaker trying to do that. With a business model that has yet to prove profitable, cash pouring out the door, and a brutally competitive outlook for the electric vehicle market even before considering any future tariff changes, the risks here are too high for me. If things go well and NIO proves its business model, the stock may well double in future. But I would want to see much more evidence of progress in that direction before I would even consider investing. The post NIO stock has halved. Could it double in future? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
